Paracetamol oral use, immediate release formulations product-specific bioequivalence guidance

  • Email
  • Help
Current version

Draft guideline

Deadline for comments: 31/10/2017

Reference numberEMA/CHMP/356877/2017
Effective from 
KeywordsBioequivalence, generics, paracetamol
DescriptionThis document provides product-specific guidance on the demonstration of the bioequivalence of paracetamol.
  • BCS Classification: Biopharmaceutics Classification System
  • AUC0-t: area under the plasma concentration curve from administration to last observed concentration at time t
  • Cmax: maximum plasma concentration

Related content

How helpful is this page?

Average rating:

 Based on 5 ratings

Add your rating:

See all ratings
1 ratings
1 ratings
1 ratings
1 ratings
1 ratings

Tell us more